NCT05971043

Brief Summary

1\. To detect the skin diseases in patients using methamphetamine

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 2, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

August 3, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2024

Completed
Last Updated

August 2, 2023

Status Verified

July 1, 2023

Enrollment Period

1 year

First QC Date

July 9, 2023

Last Update Submit

July 31, 2023

Conditions

Methamphetamine Abuse

Outcome Measures

Primary Outcomes (1)

  • skin disorders in patients using methamphetamine

    questionnaire-based study To detect the skin diseases and manifestation appears in patients using methamphetamine

    baseline

Eligibility Criteria

Age14 Years - 75 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

cross-sectional, questionnaire-based, study including clinical assessment of diseases severity.

You may qualify if:

  • Patients using methamphetamine

You may not qualify if:

  • \. Pregnant and lactating patients. 2. Patients with chronic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Barnes AJ, Smith ML, Kacinko SL, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration. Clin Chem. 2008 Jan;54(1):172-80. doi: 10.1373/clinchem.2007.092304. Epub 2007 Nov 2.

    PMID: 17981924BACKGROUND

Study Officials

  • Ahmed Shawkey gomaa, Lecturer

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

asmaa mohamed, master

CONTACT

+201097507017amelnakeeb@gmail.com

sahar ismail, professor

CONTACT

01008899446saharsotohy@yahoo.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator Dr asmaa mohamed hafez

Study Record Dates

First Submitted

July 9, 2023

First Posted

August 2, 2023

Study Start

August 3, 2023

Primary Completion

August 20, 2024

Study Completion

September 20, 2024

Last Updated

August 2, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share